Literature DB >> 30811247

Early treatment with GLP-1 after severe trauma preserves renal function in obese Zucker rats.

Lusha Xiang1,2, Michael S Thompson1, John S Clemmer1, Peter N Mittwede3, Tazim Khan1, Robert L Hester1.   

Abstract

Early posttrauma hyperglycemia (EPTH) is correlated with later adverse outcomes, including acute kidney injury (AKI). Controlling EPTH in the prehospital setting is difficult because of the variability in the ideal insulin dosage and the potential risk of hypoglycemia, especially in those with confounding medical comorbidities of obesity and insulin resistance. Glucagon-like peptide-1 (GLP-1) controls glucose levels in a glucose-dependent manner and is a current target in antidiabetic therapy. We have shown that after orthopedic trauma, obese Zucker rats exhibit EPTH and a later development of AKI (within 24 h). We hypothesized that GLP-1 treatment after trauma decreases EPTH and protects renal function in obese Zucker rats. Obese Zucker rats (~12 wk old) were fasted for 4 h before trauma. Soft tissue injury, fibula fracture, and homogenized bone component injection were then performed in both hind limbs to induce severe extremity trauma. Plasma glucose levels were measured before and 15, 30, 60, 120, 180, 240, and 300 min after trauma. GLP-1 (3 μg·kg-1·h-1, 1.5 ml/kg total) or saline was continuously infused from 30 min to 5 h after trauma. Afterwards, rats were placed in metabolic cages overnight for urine collection. The following day, plasma interleukin (IL)-6 levels, renal blood flow (RBF), glomerular filtration rate (GFR), and renal oxygen delivery (Do2) and consumption (V̇o2) were measured. EPTH was evident within 15 min after trauma but was significantly ameliorated during the 5 h of GLP-1 infusion. One day after trauma, plasma IL-6 was markedly increased in the trauma group and decreased in GLP-1-treated animals. RBF, GFR, and Do2 all significantly decreased with trauma, but renal V̇o2 was unchanged. GLP-1 treatment normalized RBF, GFR, and Do2 without affecting V̇o2. These results suggest that GLP-1 decreases EPTH and protects against a later development of AKI. Early treatment with GLP-1 (or its analogs) to rapidly, effectively, and safely control EPTH may be beneficial in the prehospital care of obese patients after trauma.

Entities:  

Keywords:  glycogen-like peptide-1; hemodynamics; hyperglycemia; kidney injury; obesity; oxygenation; trauma

Mesh:

Substances:

Year:  2019        PMID: 30811247      PMCID: PMC6589595          DOI: 10.1152/ajpregu.00312.2018

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  42 in total

1.  Early hyperglycemia predicts multiple organ failure and mortality but not infection.

Authors:  Jason L Sperry; Heidi L Frankel; Sue L Vanek; Avery B Nathens; Ernest E Moore; Ronald V Maier; Jospeh P Minei
Journal:  J Trauma       Date:  2007-09

Review 2.  Adverse Effects of GLP-1 Receptor Agonists.

Authors:  Theodosios D Filippatos; Thalia V Panagiotopoulou; Moses S Elisaf
Journal:  Rev Diabet Stud       Date:  2015-02-10

3.  Deaths: preliminary data for 2011.

Authors:  Donna L Hoyert; Jiaquan Xu
Journal:  Natl Vital Stat Rep       Date:  2012-10-10

Review 4.  Global epidemiology and outcomes of acute kidney injury.

Authors:  Eric A J Hoste; John A Kellum; Nicholas M Selby; Alexander Zarbock; Paul M Palevsky; Sean M Bagshaw; Stuart L Goldstein; Jorge Cerdá; Lakhmir S Chawla
Journal:  Nat Rev Nephrol       Date:  2018-10       Impact factor: 28.314

5.  Glucose metabolism, not obesity, predicts mortality in critically ill surgical patients.

Authors:  Nathan T Mowery; Addison K May; Bryan C Collier; Lesly A Dossett; Oliver L Gunter; Marcus J Dortch; Jose J Diaz
Journal:  Am Surg       Date:  2010-12       Impact factor: 0.688

6.  Oxidative stress contributes to orthopedic trauma-induced acute kidney injury in obese rats.

Authors:  Peter N Mittwede; Lusha Xiang; Silu Lu; John S Clemmer; Robert L Hester
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-26

7.  Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus.

Authors:  Andrew E Hogan; Gadintshware Gaoatswe; Lydia Lynch; Michelle A Corrigan; Conor Woods; Jean O'Connell; Donal O'Shea
Journal:  Diabetologia       Date:  2013-12-21       Impact factor: 10.122

Review 8.  Renal oxygenation and haemodynamics in acute kidney injury and chronic kidney disease.

Authors:  Prabhleen Singh; Sven-Erik Ricksten; Gudrun Bragadottir; Bengt Redfors; Lina Nordquist
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-02       Impact factor: 2.557

Review 9.  GIP and GLP-1, the two incretin hormones: Similarities and differences.

Authors:  Yutaka Seino; Mitsuo Fukushima; Daisuke Yabe
Journal:  J Diabetes Investig       Date:  2010-04-22       Impact factor: 4.232

10.  A novel experimental model of orthopedic trauma with acute kidney injury in obese Zucker rats.

Authors:  Peter N Mittwede; Lusha Xiang; Silu Lu; John S Clemmer; Robert L Hester
Journal:  Physiol Rep       Date:  2013-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.